Treatment of most malignant tumors is based on empiric protocols of highly toxic drugs and radiotherapy. Although there are many different kinds of cancers with numerous oncogenic alterations, novel therapeutic approaches are being designed according to the understanding of the molecular basis of cancer. A promising approach is to introduce genes which induce a great susceptibility of malignant cells to apoptosis per se or after treatment with DNA-damaging agents, regardless of the multiple genetic alterations activated in the tumor cells.
The adenovirus E1A gene fulfills these requisites and, in addition, significantly reduces the tumorigenicity of many malignant human tumor cell lines. 1 Based on previous results, 2, 3 involving retroviral E1A expression, we hypothesized that infection with adenovirus 5 expressing its own E1A gene, and depleted of the E1B genes that can overcome its cellular effects, could be effective in the treatment of malignant tumors. In the meantime, the groups of McCormick and Kirn reported that an adenovirus defective of the 55K-E1B gene (adenovirus ONYX-O15) induced a marked toxicity in malignant cells due to a replication-dependent cytolysis. 4, 5 We have studied the effect of completely E1B-defective adenovirus on many human tumor cells and on normal, nontumorigenic human cells (see Table 1 ). All the cell cultures were infected with wild-type adenovirus and 19K and 55K E1B-defective adenovirus (H5dl118), kindly provided by Dr Ginsberg, at a multiplicity of infection (MOI) of 20, except the melanocytic cell lines, which were infected at a MOI of 200. Drug treatment and cell viability were analyzed as previously described. 2, 3 Primary human cells (nonimmortalized) were highly resistant to adenovirus H5dl118-induced cytolysis. In contrast, adenovirus H5dl118 efficiently killed most tumor cell lines and produced a greater cytotoxic effect than wild-type adenovirus ( Table 1 ). The tumor cell viability of cultures infected with either H5dl118 or wildtype adenoviruses ranged from 5 to 75% at 72 h after infection (Table 1) . Lethality induced in melanoma and MCF7 breast carcinoma cell lines was less marked in relation to other malignant cell lines. Moreover, H5dl118 infection increased the sensitivity of these cell lines to DNA-damaging agents. In vivo experiments, involving injection of malignant cell lines into nude mice, showed that intratumoral injection of the vector H5dl118 reduced tumorigenicity (data not shown).
In summary, (1) completely E1B-defective adenovirus (H5dl118) exerts a marked effect on the cell viability of most malignant cell lines. The specificity of these effects is similar to that provoked by adenovirus with deletion The cell viability was assessed by staining with crystal violet after 3 days in culture. The percentages of cells are related to their respective uninfected cells.
of the 55K E1B gene (adenovirus ONYX-O15). 4, 5 (2) Moreover, H5dl118 adenovirus shows a much greater antitumoral effect than wild-type adenovirus, suggesting that other mechanisms, in addition to direct viral cytolysis, such as E1a-mediated apoptosis may be involved. (3) Finally, on the basis of our results, we propose that completely E1B-defective adenovirus, with both 19K and 55K deletions, yields a more efficient and rapid effect than wild-type adenovirus and may be considered in the treatment of human malignant tumors. 
